Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Claims about "high oral bioavailability" in humans are not evidence-based
DSIP was discovered decades ago and initially attracted substantial scientific interest, yet large contemporary clinical programs did not emerge
In preclinical studies, BPC-157 has been observed to accelerate connective tissue healing , upregulate VEGF expression , and modulate the nitric oxide (NO) pathway to support vascular integrity
Topical remedies capable of protecting skin from damage and supporting its regeneration can improve skins health as well as its appearance
Working with Veterinarians Pet owners considering investigational treatments should: Consult with a licensed veterinarian about all treatment options Discuss the evidence base (or lack thereof) for any proposed interventions Consider referral to a veterinary specialist (orthopedic surgeon, rehabilitation specialist) Ensure proper diagnosis before pursuing any treatment Understand that "research use only" compounds are not approved for animal treatment Maintain realistic expectations about experimental interventions Research Use Designation BPC-157 is available as a research peptide for laboratory investigation only
